Lantern Pharma Inc (LTRN)

Lantern Pharma Inc (LTRN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $9.6M; returns 1 day -0.8%, 1 week -4.9%, 1 year -82.8%.

Lantern Pharma Inc. (LTRN) is a clinical-stage biopharmaceutical company focused on oncology, leveraging its proprietary Artificial Intelligence (AI) and Machine Learning (ML) platform, RADR®, to accelerate and de-risk drug discovery and development.

Groups LTRN belongs to

• Clinical Stage Biotech
• Oncology
• AI in Healthcare
• Biotechnology
• Artificial Intelligence
• Drug Discovery
• Machine Learning
• Biopharmaceutical
• Cancer Therapeutics
• Healthcare Technology
• Life Sciences
• Precision Medicine
• Rare Diseases
• Clinical Stage

LTRN financial model: income statement, cash flow and balance sheet